Gerald B. Pier
Founder at Alopexx Enterprises LLC
Gerald B. Pier active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - |
Career history of Gerald B. Pier
Former positions of Gerald B. Pier
| Companies | Position | Start | End |
|---|---|---|---|
| ALOPEXX, INC. | Founder | 2019-03-22 | - |
| Corporate Officer/Principal | 2019-03-22 | - |
Training of Gerald B. Pier
| University of the Pacific | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Founder | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Health Technology |
- Stock Market
- Insiders
- Gerald B. Pier
- Experience
